Introduction

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Application
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Hunter Syndrome Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Hunter Syndrome Treatment Historical Market (2017-2023) 
    8.3    Global Hunter Syndrome Treatment Market Forecast (2024-2032)
    8.4    Global Hunter Syndrome Treatment Market by Treatment Type
        8.4.1    Enzyme Replacement Therapy (ERT)
            8.4.1.1    Historical Trend (2017-2023)
            8.4.1.2    Forecast Trend (2024-2032)
            8.4.1.3    Breakup by Type
                8.4.1.3.1    Elaprase + Tak-609 
                8.4.1.3.2    Hunterase 
                8.4.1.3.3    Izcargo 
        8.4.2    Haematopoietic Stem Cell Transplant (HSCT)
            8.4.2.1    Historical Trend (2017-2023)
            8.4.2.2    Forecast Trend (2024-2032)
            8.4.2.3    Breakup by Type
                8.4.2.3.1    Umbilical Cord Transplant    
                8.4.2.3.2    Bone Marrow Transplant
        8.4.3    Others
    8.5    Global Hunter Syndrome Treatment Market by Complications    
        8.5.1    Respiratory Disorders
            8.5.1.1    Historical Trend (2017-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Neurological Disorders  
            8.5.2.1    Historical Trend (2017-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Cardiovascular
            8.5.3.1    Historical Trend (2017-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Musculoskeletal
            8.5.4.1    Historical Trend (2017-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Gastrointestinal Disorders
            8.5.5.1    Historical Trend (2017-2023)
            8.5.5.2    Forecast Trend (2024-2032)
        8.5.6    Ophthalmic 
            8.5.6.1    Historical Trend (2017-2023)
            8.5.6.2    Forecast Trend (2024-2032)
        8.5.7    Audiologic
            8.5.7.1    Historical Trend (2017-2023)
            8.5.7.2    Forecast Trend (2024-2032)
        8.5.8    Dental
            8.5.8.1    Historical Trend (2017-2023)
            8.5.8.2    Forecast Trend (2024-2032)
        8.5.9    Others
    8.6    Global Hunter Syndrome Treatment Market by Route of Administration
        8.6.1    Intravenous
            8.6.1.1    Historical Trend (2017-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Intracerebroventricular (ICV)/ Intrathecal
            8.6.2.1    Historical Trend (2017-2023)
            8.6.2.2    Forecast Trend (2024-2032)
    8.7    Global Hunter Syndrome Treatment Market by End Use 
        8.7.1    Hospitals
            8.7.1.1    Historical Trend (2017-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Speciality Clinics
            8.7.2.1    Historical Trend (2017-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Others
    8.8    Global Hunter Syndrome Treatment Market by Distribution Channel 
        8.8.1    Hospital Pharmacy
            8.8.1.1    Historical Trend (2017-2023)
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Retail Pharmacy
            8.8.2.1    Historical Trend (2017-2023)
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Online Pharmacy
            8.8.3.1    Historical Trend (2017-2023)
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Others   
    8.9    Global Hunter Syndrome Treatment Market by Region
        8.9.1    North America
            8.9.1.1    Historical Trend (2017-2023) 
            8.9.1.2    Forecast Trend (2024-2032)
        8.9.2    Europe
            8.9.2.1    Historical Trend (2017-2023) 
            8.9.2.2    Forecast Trend (2024-2032)
        8.9.3    Asia Pacific
            8.9.3.1    Historical Trend (2017-2023) 
            8.9.3.2    Forecast Trend (2024-2032)
        8.9.4    Latin America
              8.9.4.1    Historical Trend (2017-2023) 
              8.9.4.2    Forecast Trend (2024-2032)
        8.9.5    Middle East and Africa
            8.9.5.1    Historical Trend (2017-2023) 
            8.9.5.2    Forecast Trend (2024-2032)
9    North America Hunter Syndrome Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2017-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2017-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Hunter  Syndrome Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2017-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2017-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2017-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2017-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Hunter Syndrome Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2017-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2017-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2017-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2017-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2017-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America  Hunter Syndrome Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2017-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2017-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2017-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Hunter Syndrome Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2017-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2017-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2017-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2017-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive  Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Denali Therapeutics Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    ArmaGen, Inc.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Sangamo Therapeutics Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    CANbridge Life Sciences Ltd.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    REGENXBIO Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Hunter Syndrome Treatment Market: Key Industry Highlights, 2017 and 2032
2.    Global Hunter Syndrome Treatment Historical Market: Breakup by Treatment (USD Million), 2017-2023
3.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Treatment (USD Million), 2024-2032
4.    Global Hunter Syndrome Treatment Historical Market: Breakup by Complications (USD Million), 2017-2023
5.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Complications (USD Million), 2024-2032
6.    Global Hunter Syndrome Treatment Historical Market: Breakup by Route of Administration (USD Million), 2017-2023
7.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
8.    Global Hunter Syndrome Treatment Historical Market: Breakup by End Use (USD Million), 2017-2023
9.    Global Hunter Syndrome Treatment Market Forecast: Breakup by End Use (USD Million), 2024-2032
10.    Global Hunter Syndrome Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2017-2023
11.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
12.    Global Hunter Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2017-2023
13.    Global Hunter Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
14.    North America Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
15.    North America Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Europe Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
17.    Europe Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Asia Pacific Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
19.    Asia Pacific Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Latin America Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
21.    Latin America Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
22.    Middle East and Africa Hunter Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2023
23.    Middle East and Africa Hunter Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
24.    Global Hunter Syndrome Treatment Market Structure

*Additional insights provided are customizable as per client requirements.

*The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

*The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124